APA (7th ed.) Citation

A, D., & S, T. (2026). Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment. Pharmaceutical medicine, 40(1), 19. https://doi.org/10.1007/s40290-025-00594-7

Chicago Style (17th ed.) Citation

A, Dang, and Tak S. "Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment." Pharmaceutical Medicine 40, no. 1 (2026): 19. https://doi.org/10.1007/s40290-025-00594-7.

MLA (9th ed.) Citation

A, Dang, and Tak S. "Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment." Pharmaceutical Medicine, vol. 40, no. 1, 2026, p. 19, https://doi.org/10.1007/s40290-025-00594-7.